CRMD (STOCKS)
CorMedix Inc.
$7.500000
-0.190000 (-2.47%)
Prev close: $7.690000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Joseph Todisco
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $586.98M
- Employees
- 82
- P/E (TTM)
- 3.75
- P/B (TTM)
- 1.61
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$1.26 | $0.66 | +0.6019 | +91.46% |
|
Jun 2025 (Q2)
|
$0.28 | $0.18 | +0.1037 | +58.82% |
|
Mar 2025 (Q1)
|
$0.30 | $0.27 | +0.0348 | +13.12% |
|
Dec 2024 (Q4)
|
$0.22 | $0.14 | +0.0772 | +54.06% |
Financial Statements
| Revenues | $214.30M |
| Benefits Costs and Expenses | $107.27M |
| Cost Of Revenue | $12.30M |
| Costs And Expenses | $107.27M |
| Gross Profit | $198.47M |
| Nonoperating Income/Loss | $3.08M |
| Operating Expenses | $94.52M |
| Research and Development | $12.46M |
| Other Operating Expenses | $82.06M |
| Operating Income/Loss | $103.95M |
| Income/Loss From Continuing Operations After Tax | $162.50M |
| Income/Loss From Continuing Operations Before Tax | $107.03M |
| Income Tax Expense/Benefit | -$55.47M |
| Net Income/Loss | $162.50M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $162.50M |
| Net Income/Loss Available To Common Stockholders, Basic | $162.50M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.27 |
| Diluted Earnings Per Share | $2.08 |
| Basic Average Shares | 209,987,686 |
| Diluted Average Shares | 227,993,604 |
| Assets | $750.86M |
| Current Assets | $259.54M |
| Inventory | $28.92M |
| Other Current Assets | $230.62M |
| Noncurrent Assets | $491.33M |
| Fixed Assets | $4.35M |
| Intangible Assets | $390.01M |
| Other Non-current Assets | $96.97M |
| Liabilities | $376.73M |
| Current Liabilities | $133.64M |
| Accounts Payable | $20.45M |
| Other Current Liabilities | $113.19M |
| Noncurrent Liabilities | $243.09M |
| Equity | $374.13M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $374.13M |
| Liabilities And Equity | $750.86M |
| Net Cash Flow From Operating Activities | $74.97M |
| Net Cash Flow From Operating Activities, Continuing | $74.97M |
| Net Cash Flow From Investing Activities | -$312.03M |
| Net Cash Flow From Investing Activities, Continuing | -$312.03M |
| Net Cash Flow From Financing Activities | $251.15M |
| Net Cash Flow From Financing Activities, Continuing | $251.15M |
| Exchange Gains/Losses | $102.00 |
| Net Cash Flow | $14.09M |
| Net Cash Flow, Continuing | $14.09M |
| Comprehensive Income/Loss | -$17.93M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$17.93M |
| Other Comprehensive Income/Loss | -$1.48K |